We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Optibiotix Health Plc | OPTI | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.50 | 3.51% | 14.75 | 10:40:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 14.25 | 14.00 | 14.75 | 14.75 | 14.25 |
| Industry Sector |
|---|
| HEALTH CARE EQUIPMENT & SERVICES |
| Top Posts |
|---|
Posted at 10/10/2024 10:36 by kreature Well Opti is the biggest shareholder of PBS, so that’s good, but they could have held 100% and fully controlled the scams or whatever it was that was going on there recently ? It’s no good slagging off PBS in one RNS and then congratulating them in the next |
Posted at 10/10/2024 09:19 by putinaire Could shorten the RNSWe are pleased to announce anything that covers the dodgy selling yesterday, and I want to sell PBX soon so i think it's lovely Opti O Hara |
Posted at 10/10/2024 09:17 by putinaire Re PBX yes. Much like SBTX , it should be viewed positively until O Hara's family sell them all to you. And OPTI covers more bonuses. |
Posted at 10/10/2024 09:07 by kreature ‘ These findings show SlimBiome® can have a role as a functional ingredient by itself ’Who says that as fact ? Opti I suppose. Therefore it must be true I guess |
Posted at 10/10/2024 08:23 by putinaire A nice 40% spread at PBX pre the mention in opti RNSWonder what the distribution of spread is lol |
Posted at 26/9/2024 07:19 by putinaire Well I had to chuckle. The first raise/bond/cln in a decade between opti/sbtx/pbx where selection control of who would get the play raise , was lost. Was supposed to be a closed shop for opti mates only ?"Shareholder activism led by institutional shareholders is an important aspect of corporate governance and should generally be seen as an indication that serious failings have been identified which need to be addressed in the best interests of all shareholders." |
Posted at 27/8/2024 11:54 by kreature Is anyone checking to see if the overseas manufacturer/didtrut |
Posted at 20/8/2024 10:08 by easybrent From lse chat:Looks like poor financial development in H1. In todays RNS they write “Excluding milestone payments received in H2 2023, reported revenues in H1 2024 will be ahead of H2 2023.” Lets go back and see where reported revenue were: H2 2023 £293k H1 2023 £351k H2 2022 £338k The other point to look at is what the milestone payments was in H2, OptiBiotix doesn’t give the precise number but in the 19 Jul 2023 RNS the company wrote “They are paying OptiBiotix a six-figure annual milestone in H2 every year during scale up plus”. If we assume that this milestone payment is £100k which would represent a six-figure milestone payment as per OPTI RNS. Reported revenue for H2 2023 was £293k and excluding the milestone payment it would be £193k. OptiBiotix is writing that revenue in H1 2024 is ahead of this figure, I guess fair estimate is that its in the range of £200-250k. If this is the case H1 2024 revenue is really poor, especially compared to H1 2023 revenue which was £338k. This is supposed to be growth company, but it seems to be shrinking, while the company continues to cherry pick positive development. |
Posted at 15/7/2024 12:11 by institutional investments Institutional Investments - 08 Mar 2024 - 17:16:41 - 65815 of 66446 OptiBiotix - The uncensored thread - OPTIMust be saving that 24.5 dumping beauty as a delayed for Monday. Must be pretty big Vlad The Impaler - 29 Jun 2022 - 10:08:26 - 60128 of 66446 OptiBiotix - The uncensored thread - OPTI The Maker Man has a short order in at 24.5 mid ..... Vlad wtf were we on about back then? |
Posted at 12/7/2024 12:36 by vlad the impaler OPTI cant really achieve anything on scale eitherTake past revenues (if you believe them). Now the losses. OPTI do not give margins but other similar companies do around the world. Discount on current Manu prices would be negligible on increased scale. It's why opti do not offer scaled margins to investors on the Manu & Distribution costs side We already know their products cant really be repriced then, as that element cant really change much. Plus we can derive sales as none, if play safe and discount geared receivable's. So they have no competitive new edge to introduce for the retail side Selling bulk powders to industry? Again, look globally at those that tried over the past 10 years Where are they now? I think OPTI themselves sum it up re scale, in most financials anyway example sales £320? COS £324 How many decades you all need to see the issue on scaling? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
